Cargando…
Targetting Exosomes as a New Biomarker and Therapeutic Approach for Alzheimer’s Disease
Alzheimer’s disease (AD) is a neurodegenerative disease that mainly occurs in old age and involves progressive cognitive impairment. AD has become a major global issue for public health, with approximately 24 million people currently affected by the disease. Estimates indicted that this number will...
Autores principales: | Yin, Qingqing, Ji, Xiaojuan, Lv, Renjun, Pei, Jin-Jing, Du, Yifeng, Shen, Chao, Hou, Xunyao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7025655/ https://www.ncbi.nlm.nih.gov/pubmed/32103922 http://dx.doi.org/10.2147/CIA.S240400 |
Ejemplares similares
-
Prevalence of mild cognitive impairment in type 2 diabetes mellitus is associated with serum galectin‐3 level
por: Ma, Shizhan, et al.
Publicado: (2020) -
Internet Use among Older Adults in the Era of COVID-19 in China: Challenges and Opportunities
por: Yin, Qingqing, et al.
Publicado: (2023) -
Preliminary Findings on Visual Event-Related Potential P3 in Asymptomatic Patients with Cerebral Small Vessel Disease
por: Nie, Shanjing, et al.
Publicado: (2021) -
Pathophysiological mechanisms and therapeutic approaches in obstructive sleep apnea syndrome
por: Lv, Renjun, et al.
Publicado: (2023) -
An Exosome-Based Therapeutic Strategy Targeting Neuroinflammation in Alzheimer’s Disease with Berberine and Palmatine
por: Zhao, Xin, et al.
Publicado: (2023)